RG 7834

Drug Profile

RG 7834

Alternative Names: RO-7020322

Latest Information Update: 09 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antivirals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hepatitis B

Most Recent Events

  • 23 May 2017 Roche terminates a phase I trial in Hepatitis B in New Zealand, Hong Kong and Taiwan as the molecule development has been terminated(PO) (NCT02604355)
  • 27 Apr 2017 Discontinued - Phase-I for Hepatitis B in Hong Kong, Taiwan (PO) (Roche pipeline, April 2017)
  • 27 Apr 2017 Discontinued - Phase-I for Hepatitis B in New Zealand (PO) (Roche pipeline, April 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top